The goal of this program is to improve diagnosis and management of pediatric obesity. After hearing and assimilating this program, the clinician will be better able to: 1. Cite 2023 recommendations from the American Academy of Pediatrics for management of pediatric obesity. 2. List risk factors for metabolic dysfunction-associated steatotic liver disease in pediatric obesity. 3. Explain the mechanism of action of glucagon-like peptide-1 receptor agonists. 4. Optimize use of pharmacologic treatment of pediatric obesity in patients with cardiovascular disease. 5. Use topiramate in obese pediatric patients with epilepsy.
- Provider:Lippincott Continuing Medical Education Institute, Inc.
- Activity Link: https://www.audio-digest.org/Specialties/Pediatrics
- Start Date: 2024-12-17 06:00:00
- End Date: 2024-12-17 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
- MOC Credit Details: ABP - 2.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance
- Provider Ship: Jointly Provided
- Registration: Open to all
- Specialty: Pediatric Endocrinology
Subscribe
Login
0 Comments
Oldest